Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
13
|
| pubmed:dateCreated |
1994-11-2
|
| pubmed:abstractText |
We performed portal infusion chemotherapy using a reservoir for prevention of recurrence in residual liver after hepatectomy for metastases from colo-rectal cancer. To study the usefulness of portal infusion chemotherapy, the period from hepatectomy to recurrence in residual liver was investigated by three treatment groups for H2 cases; (a) a group of systemic chemotherapy, (b) a group of arterial infusion chemotherapy and (c) a portal infusion chemotherapy group. Treatment in (a) group was for 204 +/- 98.2 days (n = 6), in (b) group for 343.0 +/- 238.3 days (n = 8) and in (c) group for 961.0 +/- 1,172.4 days (n = 5). There was no statistically significant difference in the three groups, but (c) group had a better result in recurrence in residual liver. As for prevention of recurrence in residual liver after re-hepatectomy, there was no significant difference in the three groups, but (c) group had the longest survival.
|
| pubmed:language |
jpn
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Sep
|
| pubmed:issn |
0385-0684
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
21
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
N
|
| pubmed:pagination |
2176-8
|
| pubmed:dateRevised |
2010-11-18
|
| pubmed:meshHeading |
pubmed-meshheading:7944433-Aged,
pubmed-meshheading:7944433-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:7944433-Colorectal Neoplasms,
pubmed-meshheading:7944433-Female,
pubmed-meshheading:7944433-Fluorouracil,
pubmed-meshheading:7944433-Hepatectomy,
pubmed-meshheading:7944433-Humans,
pubmed-meshheading:7944433-Infusion Pumps, Implantable,
pubmed-meshheading:7944433-Infusions, Intra-Arterial,
pubmed-meshheading:7944433-Infusions, Intravenous,
pubmed-meshheading:7944433-Liver Neoplasms,
pubmed-meshheading:7944433-Male,
pubmed-meshheading:7944433-Middle Aged,
pubmed-meshheading:7944433-Mitomycin,
pubmed-meshheading:7944433-Neoplasm, Residual,
pubmed-meshheading:7944433-Neoplasm Recurrence, Local,
pubmed-meshheading:7944433-Portal Vein,
pubmed-meshheading:7944433-Tegafur,
pubmed-meshheading:7944433-Uracil
|
| pubmed:year |
1994
|
| pubmed:articleTitle |
[The significance of portal infusion chemotherapy for prevention of recurrence in residual liver after hepatectomy for metastases from colorectal cancer].
|
| pubmed:affiliation |
Third Dept. of Surgery, Nihon University School of Medicine.
|
| pubmed:publicationType |
Journal Article,
Clinical Trial,
English Abstract,
Controlled Clinical Trial
|